Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular imaging by MRI.

Patrick M Winter1, Shelton D Caruthers, Samuel A Wickline

  • 1Cardiovascular Magnetic Resonance Laboratories, Washington University, St. Louis, MO 63110, USA.

Current Cardiology Reports
|March 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapy.

Journal of bone oncology·2026
Same author

Corrigendum to 'NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis' [Journal of Molecular and Cellular Cardiology 102 (2017) 10-21].

Journal of molecular and cellular cardiology·2026
Same author

Nucleic acid-based therapeutics to restore joint homeostasis in age-related and post-traumatic arthritis.

npj biomedical innovations·2026
Same author

Long-Term Stability of a Coronary-Encasing Cardiac Paraganglioma: A 4-Year Multimodality Imaging Follow-Up.

Circulation. Cardiovascular imaging·2026
Same author

Editorial: Emerging advances in exploiting pulmonary administration for treatment of thoracic diseases.

Frontiers in bioengineering and biotechnology·2025
Same author

Augmented expression of superoxide dismutase 2 mitigates progression and rupture of experimental abdominal aortic aneurysm.

Theranostics·2025
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
See all related articles

Molecular imaging uses MRI contrast agents to detect disease biomarkers for early diagnosis and treatment. These agents target atherosclerotic plaque features, enabling combined diagnosis and therapy for better patient outcomes.

Area of Science:

  • Biomedical imaging
  • Molecular diagnostics
  • Cardiovascular research

Background:

  • Molecular imaging aims to detect pathologic biomarkers for early disease recognition and management.
  • Magnetic Resonance Imaging (MRI) is ideal for molecular imaging due to its noninvasive nature, high resolution, and contrast.
  • Current research focuses on developing site-specific MRI contrast agents.

Purpose of the Study:

  • To explore the development and application of MRI contrast agents for molecular imaging.
  • To target specific biomarkers in diseases like atherosclerosis.
  • To combine diagnostic and therapeutic capabilities through targeted contrast agents.

Main Methods:

  • Development of site-specific MRI contrast agents.
  • Targeting of early (angiogenesis, lipid accumulation) and late (fibrin, tissue factor) atherosclerotic plaque biomarkers.

Related Experiment Videos

  • Utilizing contrast agents as potential drug delivery vehicles.

    • Main Results:

    • MRI contrast agents can be designed to target specific molecular and biologic processes.
    • These agents can detect key features of atherosclerotic plaque development and rupture.
    • The potential for dual diagnostic and therapeutic applications exists.

    Conclusions:

    • Molecular imaging with targeted MRI contrast agents offers promise for early disease detection and quantification.
    • This approach could lead to timely therapeutic interventions, preventing severe disease complications.
    • Further success of these agents will significantly advance personalized medicine and disease management.